Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

Koivula, Satu ; Taskinen, Minna ; Chen, Ping ; Holte, Harald ; Delabie, Jan ; Lindsberg, Marja Liisa Karjalainen ; Bjorkholm, Magnus ; Fluge, Oystein ; Pedersen, Lars Moller and Jerkeman, Mats LU , et al. (2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1281-1281
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
116
issue
21
pages
1281 - 1281
publisher
American Society of Hematology
conference name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
conference dates
2010-12-04 - 2010-12-07
external identifiers
  • wos:000285025203439
ISSN
1528-0020
language
English
LU publication?
yes
id
a88db225-f704-4026-94f1-b13b30741621 (old id 1917858)
date added to LUP
2016-04-01 10:48:30
date last changed
2018-11-21 19:51:10
@misc{a88db225-f704-4026-94f1-b13b30741621,
  author       = {{Koivula, Satu and Taskinen, Minna and Chen, Ping and Holte, Harald and Delabie, Jan and Lindsberg, Marja Liisa Karjalainen and Bjorkholm, Magnus and Fluge, Oystein and Pedersen, Lars Moller and Jerkeman, Mats and Eriksson, Mikael and Hautaniemi, Sampsa and Leppa, Sirpa}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  note         = {{Conference Abstract}},
  number       = {{21}},
  pages        = {{1281--1281}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study}},
  volume       = {{116}},
  year         = {{2010}},
}